| Lightcalls.com |
|
|
![]() |
The US National Cancer Institute (N...The US National Cancer Institute (NCI) has released shocking strange figures making it clear that despite the war forward breast cancer, the enemy has actually been gaining surface of land over the past 15 years. Today, numerous environmental health advocates are demanding more research into the possible character of pollutants, radiation and other environmental factors in driving the disease. The latest numbers, released October 16 2002 present to view that the Bethesda, Maryland-based agency had underestimated the incidence of cancer in the United States. Far from the previous contention that there had been a leveling most distant or a downturn in cases, of the present day breast cancer diagnoses have, in fact, been growing at a rate of 06 percent by year nationwide. That's just an average; rates vary wildly from area to area, supporting the idea of an environmental link to the disease. For instance, breast cancer leaped by 72 percent among women aged 46 to 64 in Marin shire California, during the 1990s, according to a May 2002 report in the journal Breast Cancer Research. an activists expressed outrage at the novel NCI numbers and said they were a further argument for investigating seldom-studied environmental factors. Critics complain that research institutions haven't focused enough forward this kind of investigation. Total US federal cancer research spending has increased dramatically from $90 million in 1990 to $800 million in 2001--yet les than 3 percent of those dollars have been exhausted on researching environmental links to breast cancer. In August 2002 pair San Francisco-based groups, The Breast Cancer capital and Breast Cancer Action, released The State of the Evidence, a report compiling conclusions from many breast cancer studies. The report definitely exhibits links between environmental toxins and breast cancer. Among the findings: often met with pollutants such as benzene, a pay with an abatement found in car exhaust, are linked to breast tumors, and tribe who move to industrialized areas face a higher breast cancer risk within just united generation. Says the report, "More than 50 percent of breast cancer eases remain unexplained according to the [non-environmental] characteristics and risk factors associated with the disease." "Something environmental has to be going on" says Shelley Hearne, PhD director of the nonprofit advocacy form into groups The Trust for America's Health. "We certainly haven't had a steady change in gene of like magnitude." "With the now statistically significant tend it will be less easy to be complacent," says Dale Sandler, PhD delegate chief of epidemiology at the National Institute of Environmental Health Sciences in Bethesda. "We have extremely little information on the potential part of environmental exposures in breast cancer risk, and more research is needed" Previous studies have firmly linked pollution with heart and lung disease. COPYRIGHT 2003 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |